WallStSmart

Definitive Healthcare Corp (DH)vsVeeva Systems Inc Class A (VEEV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Veeva Systems Inc Class A generates 1223% more annual revenue ($3.20B vs $241.52M). VEEV leads profitability with a 28.4% profit margin vs -57.5%. VEEV earns a higher WallStSmart Score of 69/100 (B-).

DH

Hold

37

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 5.0Quality: 6.0
Piotroski: 5/9Altman Z: -0.22

VEEV

Strong Buy

69

out of 100

Grade: B-

Growth: 8.0Profit: 8.0Value: 9.3Quality: 7.8
Piotroski: 4/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for DH.

VEEVUndervalued (+25.9%)

Margin of Safety

+25.9%

Fair Value

$238.92

Current Price

$178.11

$60.81 discount

UndervaluedFair: $238.92Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DH1 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

VEEV6 strengths · Avg: 8.5/10
Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Profit MarginProfitability
28.4%9/10

Keeps 28 of every $100 in revenue as profit

PEG RatioValuation
0.868/10

Growing faster than its price suggests

Operating MarginProfitability
29.4%8/10

Strong operational efficiency at 29.4%

Revenue GrowthGrowth
16.0%8/10

16.0% revenue growth

EPS GrowthGrowth
23.2%8/10

Earnings expanding 23.2% YoY

Areas to Watch

DH4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$118.05M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-40.4%2/10

ROE of -40.4% — below average capital efficiency

Revenue GrowthGrowth
-1.2%2/10

Revenue declined 1.2%

VEEV1 concerns · Avg: 4.0/10
P/E RatioValuation
32.9x4/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : DH

The strongest argument for DH centers on Price/Book.

Bull Case : VEEV

The strongest argument for VEEV centers on Debt/Equity, Profit Margin, PEG Ratio. Profitability is solid with margins at 28.4% and operating margin at 29.4%. Revenue growth of 16.0% demonstrates continued momentum.

Bear Case : DH

The primary concerns for DH are EPS Growth, Market Cap, Return on Equity.

Bear Case : VEEV

The primary concerns for VEEV are P/E Ratio.

Key Dynamics to Monitor

DH profiles as a turnaround stock while VEEV is a growth play — different risk/reward profiles.

DH carries more volatility with a beta of 1.66 — expect wider price swings.

VEEV is growing revenue faster at 16.0% — sustainability is the question.

VEEV generates stronger free cash flow (100M), providing more financial flexibility.

Bottom Line

VEEV scores higher overall (69/100 vs 37/100), backed by strong 28.4% margins and 16.0% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Definitive Healthcare Corp

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Definitive Healthcare Corp (DH) is a leading provider of data and analytics solutions specifically designed for the healthcare industry, catering to a diverse clientele that includes pharmaceutical companies, payers, and healthcare providers. Utilizing vast datasets and real-time analytics, DH enhances operational efficiency and informs strategic insights that drive better patient outcomes. The company is well-positioned to capitalize on the growing demand for healthcare analytics, paving the way for optimized performance amid an increasingly complex industry landscape. By partnering with key stakeholders, Definitive Healthcare focuses on delivering innovative solutions that offer a competitive edge and foster operational excellence across the sector.

Visit Website →

Veeva Systems Inc Class A

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.

Visit Website →

Want to dig deeper into these stocks?